{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:22:05Z","timestamp":1791199325171,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,30]]},"DOI":"10.7759\/cureus.47980","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T15:58:32Z","timestamp":1698681512000},"source":"Crossref","is-referenced-by-count":4,"title":["Neonatal Abstinence Syndrome: An Insight Over Impact of Maternal Substance Use"],"prefix":"10.7759","author":[{"given":"Omkar","family":"Dumbhare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.147","article-title":"Developmental consequences of fetal exposure to drugs: what we know and what we still must learn","volume":"40","author":"Ross EJ","year":"2015","unstructured":"Ross EJ, Graham DL, Money KM, Stanwood GD. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology. 2015, 40:61-87. 10.1038\/npp.2014.147","journal-title":"Neuropsychopharmacology"},{"key":"ref2","article-title":"Opioid use disorder and pregnancy","volume":"114","author":"O\u2019Donnell FT","year":"2017","unstructured":"O\u2019Donnell FT, Jackson DL. Opioid use disorder and pregnancy. Mo Med. 2017, 114:181-6.","journal-title":"Mo Med"},{"key":"ref3","article-title":"Neonatal abstinence syndrome","author":"Anbalagan S","year":"2023","unstructured":"Anbalagan S, Mendez MD. Neonatal abstinence syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051150","article-title":"Effect of prenatal opioid exposure on the human placental methylome","volume":"10","author":"Borrelli KN","year":"2022","unstructured":"Borrelli KN, Wachman EM, Beierle JA, Taglauer ES, Jain M, Bryant CD, Zhang H. Effect of prenatal opioid exposure on the human placental methylome. Biomedicines. 2022, 10:1150. 10.3390\/biomedicines10051150","journal-title":"Biomedicines"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32834fdc3a","article-title":"Neonatal abstinence syndrome","volume":"24","author":"Jansson LM","year":"2012","unstructured":"Jansson LM, Velez M. Neonatal abstinence syndrome. Curr Opin Pediatr. 2012, 24:252-8. 10.1097\/MOP.0b013e32834fdc3a","journal-title":"Curr Opin Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1561","article-title":"Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers","volume":"117","author":"Abdel-Latif ME","year":"2006","unstructured":"Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics. 2006, 117:e1163-9. 10.1542\/peds.2005-1561","journal-title":"Pediatrics"},{"key":"ref7","article-title":"Neonatal abstinence syndrome: assessment and management","volume":"2","author":"Finnegan LP","year":"1975","unstructured":"Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975, 2:141-58.","journal-title":"Addict Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000334","article-title":"Neonatal abstinence syndrome: where are we, and where do we go from here?","volume":"30","author":"Brandt L","year":"2017","unstructured":"Brandt L, Finnegan LP. Neonatal abstinence syndrome: where are we, and where do we go from here?. Curr Opin Psychiatry. 2017, 30:268-74. 10.1097\/YCO.0000000000000334","journal-title":"Curr Opin Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.04.014","article-title":"Neurobehavioral disinhibition predicts initiation of substance use in children with prenatal cocaine exposure","volume":"126","author":"Lester BM","year":"2012","unstructured":"Lester BM, Lin H, DeGarmo DS, et al.. Neurobehavioral disinhibition predicts initiation of substance use in children with prenatal cocaine exposure. Drug Alcohol Depend. 2012, 126:80-6. 10.1016\/j.drugalcdep.2012.04.014","journal-title":"Drug Alcohol Depend"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.110.6.1182","article-title":"The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants","volume":"110","author":"Lester BM","year":"2002","unstructured":"Lester BM, Tronick EZ, LaGasse L, et al.. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics. 2002, 110:1182-92. 10.1542\/peds.110.6.1182","journal-title":"Pediatrics"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2454","article-title":"Prenatal cocaine exposure and child outcomes: a conference report based on a prospective study from Cleveland","volume":"30","author":"Singer LT","year":"2015","unstructured":"Singer LT, Minnes S, Min MO, Lewis BA, Short EJ. Prenatal cocaine exposure and child outcomes: a conference report based on a prospective study from Cleveland. Hum Psychopharmacol. 2015, 30:285-9. 10.1002\/hup.2454","journal-title":"Hum Psychopharmacol"},{"key":"ref12","article-title":"Physiology, opioid receptor","author":"Dhaliwal A","year":"2023","unstructured":"Dhaliwal A, Gupta M. Physiology, opioid receptor. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000453609","article-title":"Prenatal cocaine exposure alters BDNF-TrkB signaling in the embryonic and adult brain","volume":"38","author":"McCarthy DM","year":"2016","unstructured":"McCarthy DM, Mueller KA, Cannon EN, Huizenga MN, Darnell SB, Bhide PG, Sadri-Vakili G. Prenatal cocaine exposure alters BDNF-TrkB signaling in the embryonic and adult brain. Dev Neurosci. 2016, 38:365-74. 10.1159\/000453609","journal-title":"Dev Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2004.10.007","article-title":"Predictors of motor development in children prenatally exposed to cocaine","volume":"27","author":"Miller-Loncar C","year":"2005","unstructured":"Miller-Loncar C, Lester BM, Seifer R, et al.. Predictors of motor development in children prenatally exposed to cocaine. Neurotoxicol Teratol. 2005, 27:213-20. 10.1016\/j.ntt.2004.10.007","journal-title":"Neurotoxicol Teratol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal","volume":"129","author":"Hudak ML","year":"2012","unstructured":"Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics. 2012, 129:e540-60. 10.1542\/peds.2011-3212","journal-title":"Pediatrics"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002059.pub3","article-title":"Opiate treatment for opiate withdrawal in newborn infants","volume":"6","author":"Osborn DA","year":"2010","unstructured":"Osborn DA, Jeffery HE, Cole MJ. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev. 2010, 6:CD002059. 10.1002\/14651858.CD002059.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.07.001","article-title":"Variations in opioid receptor genes in neonatal abstinence syndrome","volume":"155","author":"Wachman EM","year":"2015","unstructured":"Wachman EM, Hayes MJ, Sherva R, Brown MS, Davis JM, Farrer LA, Nielsen DA. Variations in opioid receptor genes in neonatal abstinence syndrome. Drug Alcohol Depend. 2015, 155:253-9. 10.1016\/j.drugalcdep.2015.07.001","journal-title":"Drug Alcohol Depend"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211427","article-title":"Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey","volume":"26","author":"Sarkar S","year":"2006","unstructured":"Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol. 2006, 26:15-7. 10.1038\/sj.jp.7211427","journal-title":"J Perinatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten TR","year":"2002","unstructured":"Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect. 2002, 1:13-20. 10.1151\/spp021113","journal-title":"Sci Pract Perspect"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.2640","article-title":"Neonatal abstinence syndrome: advances in diagnosis and treatment","volume":"319","author":"Wachman EM","year":"2018","unstructured":"Wachman EM, Schiff DM, Silverstein M. Neonatal abstinence syndrome: advances in diagnosis and treatment. JAMA. 2018, 319:1362-74. 10.1001\/jama.2018.2640","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016176","article-title":"Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA","volume":"7","author":"Gomez Pomar E","year":"2017","unstructured":"Gomez Pomar E, Finnegan LP, Devlin L, Bada H, Concina VA, Ibonia KT, Westgate PM. Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA. BMJ Open. 2017, 7:e016176. 10.1136\/bmjopen-2017-016176","journal-title":"BMJ Open"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2019.01.009","article-title":"Pharmacological and non-pharmacological treatments for the neonatal abstinence syndrome (NAS)","volume":"24","author":"Mangat AK","year":"2019","unstructured":"Mangat AK, Schm\u00f6lzer GM, Kraft WK. Pharmacological and non-pharmacological treatments for the neonatal abstinence syndrome (NAS). Semin Fetal Neonatal Med. 2019, 24:133-41. 10.1016\/j.siny.2019.01.009","journal-title":"Semin Fetal Neonatal Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2012.07.006","article-title":"Pharmacologic management of the opioid neonatal abstinence syndrome","volume":"59","author":"Kraft WK","year":"2012","unstructured":"Kraft WK, van den Anker JN. Pharmacologic management of the opioid neonatal abstinence syndrome. Pediatr Clin North Am. 2012, 59:1147-65. 10.1016\/j.pcl.2012.07.006","journal-title":"Pediatr Clin North Am"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota P","year":"2014","unstructured":"Kocherlakota P. Neonatal abstinence syndrome. Pediatrics. 2014, 134:e547-61. 10.1542\/peds.2013-3524","journal-title":"Pediatrics"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1039055","article-title":"The immediate and long-term effects of prenatal opioid exposure","volume":"10","author":"Yen E","year":"2022","unstructured":"Yen E, Davis JM. The immediate and long-term effects of prenatal opioid exposure. Front Pediatr. 2022, 10:1039055. 10.3389\/fped.2022.1039055","journal-title":"Front Pediatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211378","article-title":"Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure","volume":"25","author":"Bada HS","year":"2005","unstructured":"Bada HS, Das A, Bauer CR, et al.. Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol. 2005, 25:631-7. 10.1038\/sj.jp.7211378","journal-title":"J Perinatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/1535370219883601","article-title":"Developmental opioid exposures: neurobiological underpinnings, behavioral impacts, and policy implications","volume":"245","author":"Goldfarb SS","year":"2020","unstructured":"Goldfarb SS, Stanwood GD, Flynn HA, Graham DL. Developmental opioid exposures: neurobiological underpinnings, behavioral impacts, and policy implications. Exp Biol Med (Maywood). 2020, 245:131-7. 10.1177\/1535370219883601","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0128","article-title":"Prenatal opioid exposure: neurodevelopmental consequences and future research priorities","volume":"144","author":"Conradt E","year":"2019","unstructured":"Conradt E, Flannery T, Aschner JL, et al.. Prenatal opioid exposure: neurodevelopmental consequences and future research priorities\r\n. Pediatrics. 2019, 144:e20190128. 10.1542\/peds.2019-0128","journal-title":"Pediatrics"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/ANC.0000000000000778","article-title":"The role of stigma in the nursing care of families impacted by neonatal abstinence syndrome","volume":"20","author":"Recto P","year":"2020","unstructured":"Recto P, McGlothen-Bell K, McGrath J, Brownell E, Cleveland LM. The role of stigma in the nursing care of families impacted by neonatal abstinence syndrome\r\n. Adv Neonatal Care. 2020, 20:354-63. 10.1097\/ANC.0000000000000778","journal-title":"Adv Neonatal Care"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.09.014","article-title":"Epigenetic effects of cannabis exposure","volume":"79","author":"Szutorisz H","year":"2015","unstructured":"Szutorisz H, Hurd YL. Epigenetic effects of cannabis exposure. Biol Psychiatry. 2015, 79:586-94. 10.1016\/j.biopsych.2015.09.014","journal-title":"Biol Psychiatry"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/genes8030104","article-title":"The epigenetic link between prenatal adverse environments and neurodevelopmental disorders","volume":"8","author":"Kundakovic M","year":"2017","unstructured":"Kundakovic M, Jaric I. The epigenetic link between prenatal adverse environments and neurodevelopmental disorders. Genes (Basel). 2017, 8:104. 10.3390\/genes8030104","journal-title":"Genes (Basel)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.S2.634","article-title":"History and description of the neonatal intensive care unit network neurobehavioral scale","volume":"113","author":"Lester BM","year":"2004","unstructured":"Lester BM, Tronick EZ. History and description of the neonatal intensive care unit network neurobehavioral scale. Pediatrics. 2004, 113:634-40. 10.1542\/peds.113.S2.634","journal-title":"Pediatrics"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1891\/0730-0832.22.4.15","article-title":"Neonatal abstinence syndrome: strategies for care of the drug-exposed infant","volume":"22","author":"Greene C","year":"2003","unstructured":"Greene C, Goodman M. Neonatal abstinence syndrome: strategies for care of the drug-exposed infant. Neonatal Netw. 2003, 22:15-25. 10.1891\/0730-0832.22.4.15","journal-title":"Neonatal Netw"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18115973","article-title":"Nurses and pharmaceutical care: interprofessional, evidence-based working to improve patient care and outcomes","volume":"18","author":"Dilles T","year":"2021","unstructured":"Dilles T, Heczkova J, Tziaferi S, et al.. Nurses and pharmaceutical care: interprofessional, evidence-based working to improve patient care and outcomes. Int J Environ Res Public Health. 2021, 18:5973. 10.3390\/ijerph18115973","journal-title":"Int J Environ Res Public Health"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2018.10.010","article-title":"Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age","volume":"128","author":"Bakhireva LN","year":"2019","unstructured":"Bakhireva LN, Holbrook BD, Shrestha S, et al.. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age. Early Hum Dev. 2019, 128:69-76. 10.1016\/j.earlhumdev.2018.10.010","journal-title":"Early Hum Dev"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-3729.2006.00371.x","article-title":"Parenting interventions for drug-dependent mothers and their young children: the case for an attachment-based approach","volume":"55","author":"Suchman N","year":"2006","unstructured":"Suchman N, Pajulo M, DeCoste C, Mayes L. Parenting interventions for drug-dependent mothers and their young children: the case for an attachment-based approach. Fam Relat. 2006, 55:211-26. 10.1111\/j.1741-3729.2006.00371.x","journal-title":"Fam Relat"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/1940-0640-7-13","article-title":"Screening for adolescent alcohol and drug use in pediatric health-care settings: predictors and implications for practice and policy","volume":"7","author":"Sterling S","year":"2012","unstructured":"Sterling S, Kline-Simon AH, Wibbelsman C, Wong A, Weisner C. Screening for adolescent alcohol and drug use in pediatric health-care settings: predictors and implications for practice and policy. Addict Sci Clin Pract. 2012, 7:13. 10.1186\/1940-0640-7-13","journal-title":"Addict Sci Clin Pract"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogn.2021.04.014","article-title":"Integrated review of the assessment of newborns with neonatal abstinence syndrome","volume":"50","author":"Casavant SG","year":"2021","unstructured":"Casavant SG, Meegan T, Fleming M, Hussain N, Gork S, Cong X. Integrated review of the assessment of newborns with neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs. 2021, 50:539-48. 10.1016\/j.jogn.2021.04.014","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1177\/0840470416679413","article-title":"Mental illness-related stigma in healthcare: barriers to access and care and evidence-based solutions","volume":"30","author":"Knaak S","year":"2017","unstructured":"Knaak S, Mantler E, Szeto A. Mental illness-related stigma in healthcare: barriers to access and care and evidence-based solutions. Healthc Manage Forum. 2017, 30:111-6. 10.1177\/0840470416679413","journal-title":"Healthc Manage Forum"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai AH","year":"2021","unstructured":"Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017. JAMA. 2021, 325:146-55. 10.1001\/jama.2020.24991","journal-title":"JAMA"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2017.10.001","article-title":"Association of prescription drug monitoring program use with opioid prescribing and health outcomes: a comparison of program users and nonusers","volume":"19","author":"Deyo RA","year":"2018","unstructured":"Deyo RA, Hallvik SE, Hildebran C, et al.. Association of prescription drug monitoring program use with opioid prescribing and health outcomes: a comparison of program users and nonusers. J Pain. 2018, 19:166-77. 10.1016\/j.jpain.2017.10.001","journal-title":"J Pain"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9627.1000108","article-title":"Pregnancy and protection: the ethics of limiting a pregnant woman\u2019s participation in clinical trials","volume":"2","author":"Allesee L","year":"2011","unstructured":"Allesee L, Gallagher CM. Pregnancy and protection: the ethics of limiting a pregnant woman\u2019s participation in clinical trials. J Clin Res Bioeth. 2011, 2:1000108. 10.4172\/2155-9627.1000108","journal-title":"J Clin Res Bioeth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/185345-neonatal-abstinence-syndrome-an-insight-over-impact-of-maternal-substance-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:30Z","timestamp":1707509370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/185345-neonatal-abstinence-syndrome-an-insight-over-impact-of-maternal-substance-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.47980","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,30]]}}}